How to buy PAVmed stock | $5.86

PAVmed Inc is a medical devices business based in the US. PAVmed shares (PAVM) are listed on the NASDAQ and all prices are listed in US Dollars. PAVmed employs 25 staff and has a market cap (total outstanding shares value) of 0.00.

PAVmed stock price (NASDAQ: PAVM)

Use our graph to track the performance of PAVM stocks over time.

PAVmed shares at a glance

• Key figures

Information last updated 2021-10-23.

Latest market close	$5.86
52-week range	$1.63 - $9.70
50-day moving average	$7.78
200-day moving average	$6.28
Wall St. target price	$10.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.55

Buy PAVmed shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy PAVmed stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PAVmed price performance over time

Historical closes compared with the close of $5.86 from 2021-10-25

1 week (2021-10-19)	-4.56%
1 month (2021-09-24)	-36.30%
3 months (2021-07-26)	-6.09%
6 months (2021-04-26)	21.33%

1 year (2020-10-26)	210.05%
2 years (2019-10-25)	543.96%
3 years (2018-10-26)	405.17%
5 years (2016-10-22)	N/A

PAVmed financials

Gross profit TTM	$0
Return on assets TTM	-75.54%
Return on equity TTM	-259.36%
Profit margin	0%
Book value	$0.49
Market capitalisation	$484.9 million

TTM: trailing 12 months

Shorting PAVmed shares

There are currently 5.2 million PAVmed shares held short by investors – that's known as PAVmed's "short interest". This figure is 10.1% up from 4.7 million last month.

There are a few different ways that this level of interest in shorting PAVmed shares can be evaluated.

PAVmed's "short interest ratio" (SIR)

PAVmed's "short interest ratio" (SIR) is the quantity of PAVmed shares currently shorted divided by the average quantity of PAVmed shares traded daily (recently around 2.2 million). PAVmed's SIR currently stands at 2.37. In other words for every 100,000 PAVmed shares traded daily on the market, roughly 2370 shares are currently held short.

However PAVmed's short interest can also be evaluated against the total number of PAVmed shares, or, against the total number of tradable PAVmed shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PAVmed's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 PAVmed shares in existence, roughly 60 shares are currently held short) or 0.0684% of the tradable shares (for every 100,000 tradable PAVmed shares, roughly 68 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PAVmed.

Find out more about how you can short PAVmed stock.

PAVmed share dividends

We're not expecting PAVmed to pay a dividend over the next 12 months.

PAVmed share price volatility

Over the last 12 months, PAVmed's shares have ranged in value from as little as $1.63 up to $9.7. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PAVmed's is 0.2296. This would suggest that PAVmed's shares are less volatile than average (for this exchange).

PAVmed overview

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo, a disposable infusion platform technology; PortIO, an implantable intraosseous vascular access device; and DisappEAR, a resorbable pediatric ear tube, as well as NextCath and Caldus. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015.

Frequently asked questions

What percentage of PAVmed is owned by insiders or institutions?
Currently 10.873% of PAVmed shares are held by insiders and 25.063% by institutions. How many people work for PAVmed?
Latest data suggests 25 work at PAVmed. When does the fiscal year end for PAVmed?
PAVmed's fiscal year ends in December. Where is PAVmed based?
PAVmed's address is: One Grand Central Place, New York, NY, United States, 10165 What is PAVmed's ISIN number?
PAVmed's international securities identification number is: US70387R1068 What is PAVmed's CUSIP number?
PAVmed's Committee on Uniform Securities Identification Procedures number is: 70387R106